Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336

Kedudukan dalam Saham #3772
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Harga Saham
$4.87
Modal Pasaran
$4.36B
Perubahan (1 hari)
-5.47%
Perubahan (1 tahun)
-15.62%
Negara
CN
Perdagangan Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

Kategori

Healthcare
Sejarah dividen untuk Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (simbol saham: 688336) telah membuat sejumlah 5 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): $0.63
Hasil dividen (TTM): 0.0149
Pembayaran dividen untuk Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336) dari 2024 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (diselaraskan untuk pemecahan saham) Ubah
2026 (TTM) $0.45 265.85%
2025 $0.123 114.66%
2024 $0.0573 0.00%
Senarai semua pembayaran dividen
Tahun Dividen Ubah
2026 (TTM) $0.6525 265.75%
2025 $0.1784 114.94%
2024 $0.083 0.00%
Pembayaran dividen untuk syarikat serupa atau pesaing
Syarikat Jumlah pembayaran dividen Negara
0.00%
US
0.00%
US
67.00%
AU
30.00%
BE
0.00%
NL